These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20938793)

  • 1. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
    Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
    Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.
    Jacobs C; Walter C; Ziebart T; Dirks I; Schramm S; Grimm S; Krieger E; Wehrbein H
    Clin Oral Investig; 2015 Apr; 19(3):699-708. PubMed ID: 25055746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.
    Koch FP; Yekta SS; Merkel C; Ziebart T; Smeets R
    Head Face Med; 2010 Jul; 6():12. PubMed ID: 20618968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of compressive loading and incubation with clodronate on the RANKL/OPG system of human osteoblasts.
    Grimm S; Walter C; Pabst A; Goldschmitt J; Wehrbein H; Jacobs C
    J Orofac Orthop; 2015 Nov; 76(6):531-42. PubMed ID: 26446504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
    Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
    Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
    Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).
    Pan B; Farrugia AN; To LB; Findlay DM; Green J; Lynch K; Zannettino AC
    J Bone Miner Res; 2004 Jan; 19(1):147-54. PubMed ID: 14753746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro.
    Koch FP; Wunsch A; Merkel C; Ziebart T; Pabst A; Yekta SS; Blessmann M; Smeets R
    Head Face Med; 2011 Feb; 7(1):4. PubMed ID: 21299894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model.
    Çankaya M; Cizmeci Şenel F; Kadioglu Duman M; Muci E; Dayisoylu EH; Balaban F
    Int J Oral Maxillofac Surg; 2013 Sep; 42(9):1134-9. PubMed ID: 23522850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.
    Ohe JY; Kwon YD; Lee HW
    Clin Oral Investig; 2012 Aug; 16(4):1153-9. PubMed ID: 21938481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.
    Kim YH; Kim GS; Jeong-Hwa B
    Exp Mol Med; 2002 May; 34(2):145-51. PubMed ID: 12085990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
    Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Álvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
    Endocrine; 2010 Feb; 37(1):180-6. PubMed ID: 20963568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model.
    Zhu S; Häussling V; Aspera-Werz RH; Chen T; Braun B; Weng W; Histing T; Nussler AK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A; Grynpas MD; Mitchell J
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
    Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
    J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
    Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Alvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
    Endocrine; 2010 Apr; 37(2):322-8. PubMed ID: 20960270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation.
    Vasconcelos AC; Berti-Couto SA; Azambuja AA; Salum FG; Figueiredo MA; da Silva VD; Cherubini K
    J Oral Pathol Med; 2012 Oct; 41(9):702-12. PubMed ID: 22417074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.